Will Plavix be the next drug up for a genetic test? There are not many alternative drugs either that could easily replace the functionality of Plavix, it is a blood thinner. One idea would be to monitor patients with poor liver or kidney metabolization. as suggested here , a blog written...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
01-02-2009
Filed under:
Filed under: Medically Related, Technology, Insurance, Pharma/FDA News, Physician, personalized medicine, DNA, Genomics, healthcare, Health IT, Cardiology, Biotech, FDA, Information Overload, Pharmacogenomics, Sequencing, FDA warnings, Plavix
Some issues are a result of still being paper driven as timely reports and real time information are not available, but they are not the only government agency in this scenario, only one of the most critical though. Also, some members of Congress don’t use computers either and felt uncomfortable...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
11-26-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, healthcare, Medical Records, Pharma, FDA, Congress, integration, CMS, Leavitt
Personalized Medicine will create many answers and solutions in healthcare, but will we have the money to afford it? I post quite a bit about genomics and personalized medicine on the blog here and the one thing it has in common with the rest of healthcare is cost. The success of personalized...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
11-14-2008
Filed under:
Filed under: Medically Related, Technology, Insurance, Other Items of Interest, personalized medicine, healthcare, Medical Records, FDA, integration, CMS, Leavitt
This clinic is going to begin using the genomic testing for Warfarin and I might guess as more testing becomes available the plans to expand testing will continue. The link above will offer some additional information as to how personalized medicine is working it's way into healthcare today...
Recently the FDA announced it was going to use the Medicare data base in the effort to mine and help find adverse drug side effects as well as other pertinent data relative to the approval and warning process in place at the FDA. This is more than likely related to the latest technology updates...
Warfarin is the second-most-likely drug, to cause adverse events requiring hospitalization. The use of warfarin sensitivity testing in the U.S. could avoid 85,000 serious-bleeding incidents. More in the way of personalized medicine and if you were a patient determined to have an adverse reaction...
FDA loses one to private industry, where the focus is, personalized medicine. BD NEW YORK (GenomeWeb News) - Medco Health Solutions has appointed Felix Frueh to be VP of research and development, personalized medicine. Frueh formerly was associate director for genomics at the US Food and...
This is a big even in the move towards personalized medicine. This test will allow the physician to determine if the use of Herceptin is the right treatment for the patient with breast cancer! If it is determined not to work, then the patient is spared the expense and use of the drug, and...
The recent turn of events has literally put the FDA on somewhat of a hot seat... for an agency that minimally invested in technology, compared to other government entities, it is finding itself in a position of having to play "catch up" in a hurry...as evidenced with the recent turn of events...